Title : Evidence of combined therapy of dyslipoproteinemia by HMG-CoA reductase inhibitors and "essential" phospholipids.

Pub. Date : 1993 Apr

PMID : 8330475






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In 18 patients with coronary artery disease and hypercholesterolemia resistant to low-lipid diet a 12 week treatment with lovastatin (HMG-CoA reductase inhibitor) leads to the reduction of total cholesterol, LDL-cholesterol and triglycerides but also to a marked increase of platelet activity. Triglycerides 3-hydroxy-3-methylglutaryl-CoA reductase Homo sapiens